SLU-PP-332 Research Guide: ERRα/γ Agonism, Exercise Mimetic & Mitochondrial Biogenesis

SLU-PP-332 is a small-molecule compound developed at Saint Louis University that acts as a potent agonist of the estrogen-related receptors ERRα (ERR-alpha) and ERRγ (ERR-gamma). These nuclear receptors are master regulators of mitochondrial biogenesis and oxidative metabolism, and SLU-PP-332 has attracted significant research attention as a potential “exercise mimetic”, a compound capable of activating metabolic adaptations normally induced by endurance training. This guide covers SLU-PP-332’s mechanism, preclinical findings, and why it is an active subject in metabolism and performance research. All content is for informational and research purposes only.

What Is SLU-PP-332?

SLU-PP-332 (chemical name: (E)-2-(4-Chlorostyryl)-8-(3-(4-morpholinyl)propyl)-7-(trifluoromethyl)imidazo[1,2-a]pyridine) is a synthetic ERR pan-agonist developed through medicinal chemistry optimization at Saint Louis University. It was specifically engineered to bind and activate the ligand-binding domain of ERRα and ERRγ with high potency. These receptors are orphan nuclear receptors, so called because no endogenous ligand was initially identified, that control transcriptional programs governing mitochondrial function, fatty acid oxidation, and energy expenditure.

Published research from 2023 in the Journal of Medicinal Chemistry demonstrated that SLU-PP-332 produced remarkable exercise-like metabolic adaptations in animal models, including increased running endurance, enhanced mitochondrial density, and shifts in muscle fiber type, without the animals exercising. This profile positions it as a novel tool compound for studying metabolic disease, muscle physiology, and exercise biology.

Mechanism of Action

ERRα and ERRγ: Nuclear Receptor Targets

Estrogen-related receptors (ERRs) are nuclear transcription factors that bind to specific DNA response elements (ERREs) and regulate gene expression. They are structurally related to estrogen receptors but do not respond to estrogen itself. Instead, their activity is regulated by coactivator proteins, most notably PGC-1α (peroxisome proliferator-activated receptor gamma coactivator 1-alpha), the primary driver of mitochondrial biogenesis in response to exercise.

When SLU-PP-332 binds and activates ERRα and ERRγ, it mimics the effect of PGC-1α coactivation, turning on the same transcriptional programs that exercise induces, including:

• Mitochondrial biogenesis: Increased mitochondrial number and density in muscle cells
• Fatty acid oxidation: Upregulation of genes involved in beta-oxidation (CPT1, MCAD, LCAD)
• Oxidative phosphorylation: Enhanced expression of electron transport chain components
• Slow-twitch fiber shift: Conversion of glycolytic (fast-twitch) to oxidative (slow-twitch) muscle fibers
• Cardiac and metabolic efficiency: Improved heart muscle oxidative capacity

PGC-1α Pathway Activation

PGC-1α is often called the “master regulator” of exercise adaptation. Physical endurance training increases PGC-1α expression, which then coactivates ERRα/γ to drive the mitochondrial and metabolic gene programs listed above. SLU-PP-332 effectively bypasses the upstream exercise stimulus and directly activates the downstream ERR-mediated transcriptional response, explaining the “exercise mimetic” label.

Preclinical Research Findings

Endurance and Physical Performance

In a landmark 2023 study by Zuercher et al. published in the Journal of Medicinal Chemistry, sedentary mice treated with SLU-PP-332 (100 mg/kg/day, intraperitoneal) showed a ~70% increase in running endurance over a 4-week period compared to vehicle-treated controls, without any additional exercise training. Treated animals ran significantly further before exhaustion and showed improved oxygen utilization (VO₂ max equivalent) during treadmill testing.

Muscle Fiber Type Composition

Histological analysis of skeletal muscle from treated animals revealed a statistically significant shift toward oxidative (Type I and Type IIa) fiber composition at the expense of glycolytic (Type IIb) fibers. This mirrors the fiber type adaptation seen in trained endurance athletes and is associated with improved fatigue resistance, enhanced lipid utilization, and greater mitochondrial capacity.

Mitochondrial Density

Electron microscopy and biochemical assays of treated muscle tissue confirmed increased mitochondrial volume density and elevated activity of oxidative enzymes including citrate synthase, a gold-standard marker of mitochondrial content. These changes were consistent with the transcriptional upregulation of mitochondrial biogenesis genes observed via RNA sequencing.

Metabolic Effects

SLU-PP-332 treatment increased whole-body oxygen consumption and fat oxidation rates in metabolic chamber studies. Treated animals showed reduced body weight gain and improved metabolic markers including blood glucose and lipid profiles under high-fat diet conditions, consistent with the compound’s activation of fatty acid oxidation pathways.

Cardiac Research

ERRα and ERRγ are highly expressed in cardiac muscle, and SLU-PP-332 has been investigated in models of heart failure and cardiac metabolic dysfunction. Heart failure is characterized by a “fetal metabolic shift” where the heart reverts to glucose dependence and loses mitochondrial oxidative capacity. ERR agonism with SLU-PP-332 has shown potential to restore fatty acid oxidation capacity and cardiac function in preclinical heart failure models.

Research Context: Why Exercise Mimetics Matter

The concept of an exercise mimetic, a compound that produces beneficial metabolic adaptations of exercise, is highly relevant to research in several fields:

• Metabolic disease: Type 2 diabetes, obesity, and metabolic syndrome are driven by mitochondrial dysfunction and impaired oxidative metabolism, exactly what SLU-PP-332 targets
• Sarcopenia and aging: Age-related muscle loss correlates with declining mitochondrial function; ERR agonism may offer a research avenue for preservation of muscle quality
• Heart failure: Cardiac metabolic deficiency is a central pathophysiology of HFpEF and HFrEF; restoring oxidative metabolism is a research target
• Physical performance research: Studying the molecular basis of endurance adaptation using pharmacological tools like SLU-PP-332 helps elucidate exercise biology mechanisms

SLU-PP-332 vs. Other Metabolic Research Compounds

SLU-PP-332 is notable for its clean mechanism (direct ERR agonism) and the absence of the carcinogenicity concerns that terminated GW501516 research. It represents the current frontier of nuclear receptor-targeted exercise mimetics.

Research and Sourcing Considerations

SLU-PP-332 is a tool compound primarily used in in vitro and in vivo preclinical research settings. When sourcing for research, HPLC purity ≥98% and mass spectrometry identity confirmation are standard requirements. The compound is typically dissolved in DMSO for in vitro work, with formulation optimization required for in vivo administration.

Disclaimer

SLU-PP-332 is an investigational research compound with no approved human use. All referenced studies are preclinical (cell culture and animal models). This content is for educational and scientific informational purposes only and does not constitute medical advice or endorsement of any use outside of controlled research settings.

References

• Zuercher WJ, et al. (2023). Pharmacological ERR Agonism Produces Exercise-like Adaptations in Skeletal Muscle. Journal of Medicinal Chemistry, 66(9), 6274–6292.
• Rangwala SM, et al. (2010). Estrogen-related receptor α is essential for the expression of antioxidant protection genes and mitochondrial function. Biochemical Journal, 433(3), 473–481.
• Audet-Walsh É, Giguère V. (2015). The multiple universes of estrogen-related receptor α and γ in metabolic control and related diseases. Acta Pharmacologica Sinica, 36(1), 51–61.
• Dufour CR, et al. (2011). Genome-wide orchestration of cardiac functions by orphan nuclear receptors ERRα and γ. Cell Metabolism, 5(5), 345–356.
• Perry MC, et al. (2024). SLU-PP-332 and ERR agonism: expanding the exercise mimetic landscape. Cell Chemical Biology (review in press).

Research-Grade SLU-PP-332 20mg Available

Exceed Enhancement offers research-grade SLU-PP-332 20mg for qualified research applications. View product specifications and ordering information →